Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jane Huang currently holds 86,917 shares of Prelude Therapeutics Inc (PRLD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jane Huang has been a net seller of PRLD stock. They have purchased $0 and sold $39.8M worth of shares.
Jane Huang's most recent insider trade was on Oct 4, 2025, when they sold 3,355 shares at $1.47 per share.
Jane Huang serves as Executive at Prelude Therapeutics Inc (PRLD). They have executed 274 insider transactions totaling $39.8M over their tenure at the company.
Jane Huang holds the position of Executive at Prelude Therapeutics Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Jane Huang has shown a selling trading pattern, with $0 in total purchases and $39.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jane Huang was on Dec 1, 2021, when they sold $189.4K worth of BGNE shares. This transaction involved 530 shares at $357.32 per share.
Jane Huang currently owns 86,917 shares of Prelude Therapeutics Inc (PRLD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jane Huang's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jane Huang has 274 Form 4 filings on record as an insider at Prelude Therapeutics Inc.
Set alerts for Jane Huang and 40,000+ other insiders.